CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)64398-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Correction: Genomic Deletion of Chromosome 12p Is an Independent Prognostic Marker in Prostate Cancer

Oncotarget
Oncology
2017English

Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

High YKL-40 Is Associated With Poor Survival in Patients With Renal Cell Carcinoma: A Novel Independent Prognostic Marker

Scandinavian Journal of Urology
UrologyNephrology
2017English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy